Gapping down
In reaction to earnings/guidance:
- BNGO -7.8%, VLDR -4.8% (guides Q4 revs below consensus, cites COVID-19 related disruptions), NBIX -3.7%, ASX -0.6%
Other news:
- SRPT -47.5% (reports data for SRP-9001 for the treatment of Duchenne; primary endpoint did not achieve statistical significance)
- SLDB -20.4% (in sympathy with clinical data release from SRPT)
- GXGX -8.6% (GX Acquisition Corp and Celularity announce merger agreement to create a publicly listed leader in allogeneic cellular therapy)
- BNGO -7.6% (stock offering)
- CERC -6.2% (prices offering of 12,323,077 shares of common stock at $2.60 per share and pre-funded warrants to purchase up to an aggregate of 1,676,923 shares of common stock at a purchase price of $2.599 per pre-funded warrant)
- UBER -4% (union announces effort in Chicago to drive up wages, according to FreightWaves.com)
- CS -2.6% (provides updates on trading and Q4 RMBS-related provisions; expects to report loss in Q4)
- BLNK -1.8% (prices public offering of 5,400,000 shares of its common stock at a public offering price of $41.00 per share, for total gross proceeds of approximately $221.4 mln) ARGX -1.6% (provides priority outlook and cash burn for 2021ahead of J.P. Morgan Healthcare Conference)
- MOD -1% (COO resigns)
Analyst comments:
- SCWX -4.2% (downgraded to Sell from Neutral at Goldman)
- XYL -3.2% (downgraded to Mkt Perform from Outperform at Raymond James;downgraded to Underperform from Market Perform at Cowen)
- AEG -2.3% (downgraded to Hold from Buy at HSBC Securities)
- AVA -1.9% (downgraded to Underperform from Neutral at BofA Securities)
- CMC -0.8% (downgraded to Hold from Buy at Deutsche Bank)